PresentationRyan KruegerManaging Director of Equity Research I'm Ryan Krueger, Life Insurance Analyst at KBW. It's great to have MetLife back with us again this year. Up on stage with me to my immediate right is Michel Khalaf, President and CEO, to the far right is John McCallion, CFO and Head of MetLife Investment Management. Also want to acknowledge John Hall, Treasurer and Head of Investor Relations; and other members of the IR team in the front row. So with that, Michel you launched a new 5-year strateg ...

Quarterly Performance and Key Developments The company's results fell short of analyst estimates, both on non-GAAP adjusted earnings and revenue. Earnings per share (non-GAAP) were 6.0% below consensus, and Revenue (Non-GAAP) missed analyst estimates by approximately $5.8 billion. Net income (GAAP) declined by nearly 23% year-over-year, with profitability pressured by several factors. Segment results showed a clear divergence. In Group Benefits -- which covers employer life and health insurance products -- ...

Financial Data and Key Metrics Changes - Adjusted earnings for Q1 2025 were $1.3 billion, or $1.96 per share, representing a 7% increase from the same period last year [11][24] - Adjusted return on equity was 14.4%, with a direct expense ratio of 12%, indicating operational efficiency [11][35] - Adjusted earnings were up 1% year-over-year, and 5% on a constant currency basis, driven by favorable life underwriting and higher variable investment income [24][25] Business Segment Data and Key Metrics Changes - Group Benefits adjusted earnings were $367 million, up 29% year-over-year, attributed to favorable life underwriting margins due to lower mortality [12][25] - Retirement and Income Solutions (RIS) adjusted earnings totaled $400 million, with strong sales in synthetic GICs and UK longevity reinsurance, and inflows from pension risk transfers of $1.8 billion [13][27] - Asia adjusted earnings were $374 million, down 12% year-over-year, impacted by lower underwriting margins and higher taxes, although sales were up 10% [14][29] - Latin America adjusted earnings were $218 million, down 6% year-over-year, but up 7% on a constant currency basis, with adjusted PFOs up 1% reported and 14% constant currency [14][30] Market Data and Key Metrics Changes - The U.S. dollar has started to weaken against many currencies, which may benefit international business growth [7][9] - The company noted that the underlying growth of international businesses could emerge as a tailwind despite being masked by the strong dollar [9][12] Company Strategy and Development Direction - The company has rolled out a "New Frontier" strategy aimed at guiding operations over the next five years, focusing on strategic diversification and resilience [6][10] - A significant risk transfer deal was announced, reinsuring approximately $10 billion of U.S. retail variable annuity reserves, aimed at reducing enterprise risk [16][40] - The company is on a path to achieve $1 trillion in total assets under management for MetLife Investment Management [16] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to navigate the uncertain economic environment, emphasizing a recurring revenue business model [8][20] - The company is focused on executing its strategy without significant changes, despite rising recession risks [75][76] - Management highlighted strong fundamentals and a commitment to responsible growth and attractive returns [43] Other Important Information - The company returned approximately $1.8 billion to shareholders through dividends and share repurchases in Q1 2025 [17][36] - A new $3 billion share repurchase authorization was announced, reflecting confidence in financial strength [18][36] - The effective tax rate on adjusted earnings was 23.2%, slightly below the 2025 guidance range [33] Q&A Session Summary Question: Inquiry about spreads in the RIS business - Management acknowledged a sequential decline in spreads due to interest rate gaps and lower rates than expected, but noted growth momentum in the business [46][52] Question: Comments on the CRE portfolio and recovery indications - Management indicated that while there are signs of stabilization in the commercial mortgage loan book, ongoing uncertainty may impact momentum [56][58] Question: Discussion on the risk transfer deal valuation - Management explained that the deal was structured to reduce tail risk and was aligned with their economic valuation expectations, despite a loss in net income [63][67] Question: Underwriting experience in MetLife Holdings - Management reported that underwriting experience was consistent across both life insurance and long-term care segments [70][71] Question: Current environment's influence on capital management strategy - Management confirmed that while they are aware of the economic environment, their strategy remains focused on executing existing plans without significant changes [74][76] Question: Insights on PRT sales and market activity - Management noted that while market volatility can be a distraction, it does not significantly alter the pipeline for pension risk transfer transactions [90][91] Question: Expectations for variable investment income in 2025 - Management indicated that while Q1 results were strong, predicting future performance remains challenging due to market volatility [95][98]

Financial Data and Key Metrics Changes - The company reported adjusted earnings of $1,300,000,000 or $1.96 per share, up 7% from the same period a year ago, driven by favorable underwriting and good volume growth [11][24] - Adjusted return on equity in the first quarter was 14.4%, with a direct expense ratio of 12%, indicating efficiency [11][36] - Adjusted earnings were $1,300,000,000, up 1% year over year, and up 5% on a constant currency basis [24] Business Segment Data and Key Metrics Changes - Group Benefits adjusted earnings were $367,000,000, up 29% from the prior year due to favorable life underwriting margins [12][25] - Retirement and Income Solutions (RIS) adjusted earnings totaled $400,000,000, with strong sales in synthetic GICs and UK longevity reinsurance [13][28] - Asia adjusted earnings were $374,000,000, down 12% year over year, primarily due to lower underwriting margins and higher taxes [13][30] - Latin America adjusted earnings were $218,000,000, down 6%, but up 7% on a constant currency basis [14][31] - EMEA adjusted earnings were $83,000,000, up 8% and up 14% on a constant currency basis [32] Market Data and Key Metrics Changes - The company noted that the U.S. dollar has started to weaken against many currencies, which could benefit international business growth [9][10] - The company experienced favorable life underwriting margins due to lower mortality rates in the working-age population, consistent with CDC data [12][26] Company Strategy and Development Direction - The company has rolled out its New Frontier strategy to guide operations over the next five years, focusing on strategic diversification and resilience [7][10] - A significant risk transfer deal was announced, reinsuring approximately $10,000,000,000 of U.S. Retail variable annuity and rider reserves, aimed at reducing enterprise risk [16][40] - The company aims to achieve $1,000,000,000,000 in total assets under management through MetLife Investment Management [17] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to navigate the uncertain economic environment, emphasizing the all-weather nature of its business model [9][20] - The company is focused on executing its strategy without significant changes, despite rising recession risks [73][75] - Management highlighted strong underlying fundamentals and a commitment to responsible growth and attractive returns [43][44] Other Important Information - The company returned approximately $1,800,000,000 to shareholders through dividends and share repurchases in the first quarter [18][19] - The Board of Directors increased the common dividend per share by 4.1% [19] - The company ended the quarter with $4,500,000,000 in cash and liquid assets, above its target cash buffer [37][39] Q&A Session Summary Question: On spreads in the RIS business - Management acknowledged a sequential decline in spreads due to interest rate gaps and lower rates than expected, but noted growth momentum in the business [46][52][54] Question: On the commercial mortgage loan book - Management indicated that while there are signs of stabilization in real estate activity, uncertainty may slow momentum [56][58] Question: On the risk transfer deal valuation - Management explained that the deal was evaluated from multiple perspectives, including economic value and the removal of tail risk, which justified the transaction [62][66] Question: On underwriting experience in MetLife Holdings - Management reported that underwriting experience was in line with expectations across both life insurance and long-term care [68][69] Question: On capital management strategy in the current environment - Management confirmed that there would be no changes to capital management strategy, focusing on executing their existing strategy [72][75] Question: On PRT sales and market volatility - Management noted that while market volatility can be a distraction, it does not significantly impact the pipeline of transactions in the PRT space [87][90] Question: On variable investment income outlook - Management indicated that while the current environment poses challenges, they plan to provide preliminary information on expectations for variable investment income in July [94][96] Question: On the implementation of ESR in Japan - Management expressed confidence in operational readiness and indicated that the new framework would not change their operational approach [99][100]